Page last updated: 2024-10-31

w 12 and Multiple Sclerosis

w 12 has been researched along with Multiple Sclerosis in 1 studies

W 12: calmodulin antagonist; W13 analog with Cl deleted from benzene ring

Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Maddess, T1
van Kleef, JP1
Rohan, EMF1
Carle, CF1
Baird-Gunning, J1
Rai, BB1
Bruestle, A1
Lane, J1
Lueck, CJ1

Other Studies

1 other study available for w 12 and Multiple Sclerosis

ArticleYear
Rapid, non-contact multifocal visual assessment in multiple sclerosis.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2023, Volume: 44, Issue:1

    Topics: Humans; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Pupil; Visual Field Tests; Visu

2023